Cj. Tseng et al., MODULATORY EFFECTS OF ENDOGENOUS ADENOSINE ON EPINEPHRINE SECRETION FROM THE ADRENAL-MEDULLA OF THE RAT, Hypertension, 24(6), 1994, pp. 714-718
The purpose of this study was to examine (1) whether endogenous adenos
ine receptors inhibit the release of epinephrine and norepinephrine fr
om adrenal medulla in response to physiological and pharmacological st
imuli and (2) whether the renin-angiotensin system modulates this effe
ct of endogenous adenosine. We used a conscious animal model to approx
imate normal physiological conditions. Male Sprague-Dawley rats were t
reated with a surface adenosine receptor antagonist, 1,3-dipropyl-8-(p
-sulfophenyl)xanthine (DPSPX) to explore the effect of endogenous aden
osine. Plasma epinephrine and norepinephrine levels in response to hyd
ralazine-induced hypotension were measured in these animals. The same
protocol was repeated in rats pretreated with either adrenalectomy or
captopril. The results showed that DPSPX treatment significantly incre
ased plasma epinephrine and norepinephrine levels at both baseline con
ditions and after hydralazine-induced hypotension. The results from th
e adrenalectomized rats showed that the difference in plasma epinephri
ne level between the control and DPSPX groups originated from the adre
nal medulla. Pretreatment with captopril attenuated the rise of plasma
epinephrine and norepinephrine levels in DPSPX-treated animals. This
result suggests that endogenous adenosine receptors inhibit epinephrin
e release from the adrenal medulla and suppress plasma norepinephrine
levels. When catecholamine release was stimulated by physiological and
pharmacological stimuli, this inhibitory function of adenosine recept
ors was augmented. The renin-angiotensin system is at least partially
responsible for the modulatory function of endogenous adenosine on the
catecholamine response as demonstrated in this study.